iCell GABANeurons AD APOE E4/E4, 01434

Human iPSC-derived GABA neurons from a Caucasian female (age <18) with an Alzheimer's disease (AD) phenotype (genotype: APOE E4/E4), differentiated from fibroblast-derived iPSCs.

Model Alzheimer's pathology and fuel drug discovery with iCell® GABANeurons AD APOE E4/E4, 01434, derived from human induced pluripotent stem cells (iPSCs).

  • Disease relevance With the high-risk APOE E4/E4 genotype, these cells enable the study of Alzheimer’s mechanisms and pathology.
  • Isogenic control Isogenic iCell GABANeurons, 01434 are available for precise interpretation of APOE E4-specific effects.
  • High purity Stringent quality control ensures each batch provides a >95% pure predominantly GABAergic neuronal population.
  • Consistent performance Lot-to-lot consistency in phenotype and viability ensures reproducible experiments.
  • Ready-to-use Arriving fully differentiated and cryopreserved, these cells require no further induction or selection steps.
Catalog # E401434

Products

Kits

  • 1 vial Cryopreserved iCell GABANeurons AD APOE E4/E4, 01434
  • 100 ml Neural Base Medium 1
  • 2 ml Neural Supplement A
  • User’s Guide

genetic status

Quantity (Cells Per Vials)

Catalog #

Catalog #:

Alzheimer's Disease differentiated from human iPS cells, frozen

From
$2,545.00

Cells Only

  • 1 vial Cryopreserved iCell GABANeurons AD APOE E4/E4, 01434
  • User’s Guide

genetic status

Quantity (Cells Per Vials)

Catalog #

Catalog #:

Alzheimer's Disease differentiated from human iPS cells, frozen

From
$2,445.00

Product Overview

Apolipoprotein E gene (APOE) is a cholesterol-carrying protein involved in lipid metabolism, neuronal growth, synaptic maturation, and cellular repair. The composition of APOE, which has three polymorphic alleles (E2, E3, and E4), is a major risk factor Alzheimer’s disease (AD). The presence of two APOE E4 alleles is the highest risk factor for developing AD as well as non-AD age related cognitive decline. While the contribution of APOE E4 in AD pathogenesis is thought to involve altered lipid transport and metabolism in neurons and glia, additional mechanisms underlying its contribution to AD are still being elucidated.

iCell GABANeurons AD APOE E4/E4 were developed as cellular model to investigate the mechanisms underlying ApoE4/E4 risk in developing AD as well as potential therapeutic treatments. The APOE E4/E4 cell line was engineered from the isogenic parental APOE E3/E3 induced pluripotent stem cell line, followed by differentiation into cortical neurons that exhibit a majority GABAergic phenotype.

Features of iCell GABANeurons APOE 4/4:

  • >95% pure neuronal population with a majority of GABAergic (inhibitory) neurons
  • Consistent lot-to-lot GABA phenotypes and cell viability
  • Isogenic iCell GABANeurons, 01434 are available

View all Alzheimer’s disease cell models here.

Components:

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Product Highlights

Applications: